Printer Friendly

Browse Clinical trials topic

Health aspects subtopic

 

Articles

1-300 out of 600 article(s) nextnext page
Title Author Type Date Words
Gram-Negative Bacterial Infections Global Clinical Trials Review, H2, 2017. Sep 28, 2017 585
Influenza A Virus, H1N1 Subtype Infections Global Clinical Trials Review, H2, 2017. Sep 28, 2017 597
AbbVie and Bristol-Myers Squibb Announce Clinical Research Collaboration to Evaluate a Therapeutic Regimen in Advanced Solid Tumors. Sep 22, 2017 4365
Ear Infections Global Clinical Trials Review, H2, 2017. Sep 20, 2017 581
MeMed Completes Trilogy of Clinical Studies with More Than 2,000 Patients Validating First Ever Blood Test to Accurately Distinguish Between Bacterial and Viral Infections. Clinical report Sep 18, 2017 1169
DelMar Pharmaceuticals Initiates Phase 2 Clinical Trial in Newly Diagnosed MGMT-unmethylated Glioblastoma Multiforme. Sep 11, 2017 1455
Canada : Aequus Announces Positive Results for Proof of Concept Clinical Trial of Anti-Nausea Patch. Financial report Sep 8, 2017 495
EnGeneIC Announces Publication in The Lancet Oncology of First Clinical Study Employing EDV(TM) Nanocell Platform to Enable microRNA Replacement Therapy. Clinical report Sep 5, 2017 734
Gliknik Announces Dosing Of First Patient In Phase 2 Trial Targeting Prevention Of Recurrence Of High-Risk Oral Cavity Cancer. Aug 28, 2017 737
Cytomegalovirus (HHV-5) Infections Global Clinical Trials Review, H2, 2017. Aug 23, 2017 571
ViraCyte Announces Positive Phase 2 Trial Results. Aug 22, 2017 514
PolyPid Ltd. Completes Enrollment in Phase Ib/II Study of D-PLEX(TM) in Post-Cardiac Surgery Sternal Infection. Aug 16, 2017 786
Theravance Biopharma Reports Encouraging Data from First Cohort of Patients in Phase 1b Clinical Trial of TD-1473 in Ulcerative Colitis. Aug 8, 2017 2169
Rebiotix Announces First Patient Enrolled in Phase 3 Clinical Trial of RBX2660 for the Prevention of Recurrent Clostridium difficile Infection. Aug 7, 2017 925
Umbilical vein injection of misoprostol versus normal saline for the treatment of retained placenta in a tertiary care centre- a non-randomised controlled trial. Patra, Kajal Kumar; Chattopadhyay, Shibram; Dey, Amarnath; Sarkar, Chaitali; Chakraborty, Anaindita; Report Jul 27, 2017 2349
United Kingdom : Faslodex receives EU approval as first-line therapy for advanced breast cancer. Jul 27, 2017 450
Sequoia Sciences Receives FDA Fast Track Designation for Vaccine for Urinary Tract Infections Caused by Multidrug-Resistant Bacteria. Jul 26, 2017 1012
Sequoia Sciences Receives FDA Fast Track Designation for Vaccine for Urinary Tract Infections Caused by Multidrug-Resistant Bacteria. Jul 26, 2017 1043
DelMar Pharmaceuticals Receives Approval from China's Human Genetic Resources Administration to Initiate Phase 2 Clinical Trial in Newly Diagnosed GBM. Jul 24, 2017 1588
DelMar Pharmaceuticals Announces Completion of First Site Initiation Visit for STAR-3 Pivotal Phase 3 Clinical Trial of VAL-083 in Refractory GBM. Jul 18, 2017 1409
Meissa Vaccines awarded $1.6m Fast Track SBIR Grant to advance IND preparations for RSV vaccine candidate. Jul 12, 2017 520
ViraCyte Completes Phase 1 Clinical Trial of Viralym-C. Jul 11, 2017 444
Crestovo Begins Clinical Trial of Microbiome Therapy for the Prevention of Recurrent Clostridium Difficile Infection. Jun 28, 2017 236
Agreement will see new bladder cancer therapy move to clinical trials. Jun 27, 2017 275
Agreement will see new bladder cancer therapy move to clinical trials. Jun 27, 2017 271
DelMar Pharmaceuticals Receives Institutional Review Board Approval for Pivotal Phase 3 Clinical Trial of VAL-083 in Refractory GBM. Jun 22, 2017 1175
DelMar Presents Poster of Clinical Research with VAL-083 in Patients with Chemo-resistant Glioblastoma ("GBM") at SNO's Pediatric Neuro-Oncology Basic and Translational Research Conference. Conference news Jun 16, 2017 1191
Clinical discoveries that have proved life-savers; The vital contribution of people in research was celebrated last month as part of International Clinical Trials Day. Here, health correspondent Mark Smith looks at 10 healthcare breakthroughs that could only have been discovered through research. Jun 14, 2017 979
Seres Therapeutics Begins Phase 3 Study of SER-109 for Treatment of Multiply Recurrent C. difficile Infection. Jun 13, 2017 274
Clinical discoveries that have proved life-savers; The vital contribution of people in research was celebrated last month as part of International Clinical Trials Day. Here, health correspondent Mark Smith looks at 10 healthcare breakthroughs that could only have been discovered through research. Jun 12, 2017 976
United States : Protocol Submitted to FDA for Phase 2 Clinical Trial of ProscaVax as Immunotherapy for Early-Stage Prostate Cancer. Jun 3, 2017 461
Large doses of vitamin C can boost cancer treatment: In a clincal trial, standard cancer therapies, such as radiation and chemotherapy, are enhanced via vitamin C infusions. Jun 1, 2017 619
Siblings take on Battens disease in new therapy trial. May 31, 2017 408
Phase III clinical trial spells new hope for patients with hard-to-treat form of cancer. May 19, 2017 526
Phase III clinical trial spells new hope for patients with hard-to-treat form of cancer. May 19, 2017 530
United States : Sirnaomics received IND approval from CFDA for its leading siRNA Therapeutic Candidate, STP705, for treatment of Hypertrophic Scar. May 2, 2017 465
Entrinsic Health Solutions Completes Enrollment for Enterade Clinical Trial. May 1, 2017 328
France,United States : Transgene and Bristol-Myers Squibb Announce Clinical Research Collaboration to Evaluate TG4010 in Combination with Opdivo and Standard Chemotherapy in First Line Non-Small Cell Lung Cancer. Apr 28, 2017 376
DelMar to Present Poster of Clinical Research with VAL-083 in Patients with Chemo-Resistant Glioblastoma ("GBM") at ASCO Annual Meeting. Apr 27, 2017 1263
Aspyrian announces the presentation of clinical data of its investigational therapy RM-1929 demonstrating significant anti-cancer response in recurrent Head and Neck Cancer patients who have failed all existing treatment options. Apr 27, 2017 944
First patient treated in Turnstone's lung cancer trial combining novel viral cancer therapy with approved checkpoint inhibitor. Apr 26, 2017 673
Vitamin D may protect against colds and flu: study analyzed data from 11,000 participants in 25 clinical trials conducted in 14 countries. Apr 1, 2017 765
Servier and Pfizer begin trials for off-the-shelf T-cell cancer therapy. Mar 10, 2017 248
Servier and Pfizer begin trials for off-the-shelf T-cell cancer therapy. Mar 10, 2017 244
From molecules to health outcomes--ever wondered how to critically analyse molecular biology, cell biology and clinical trial scientific papers? Bugarcic, Andrea Mar 1, 2017 236
Therapeutic efficacy of nutritional support by percutaneous endoscopic gastrostomy in critically ill patients: A self-control clinical trial. Feb 28, 2017 3351
Faron Pharmaceuticals recruits first patient for Phase II clinical trials for second major indication for Traumakine. Feb 20, 2017 231
Faron Pharmaceuticals recruits first patient for Phase II clinical trials for second major indication for Traumakine. Feb 20, 2017 227
Emergent BioSolutions commences Phase 1b multiple ascending dose study to assess UV-4B. Report Feb 3, 2017 207
Emergent BioSolutions commences Phase 1b multiple ascending dose study to assess UV-4B. Report Feb 3, 2017 203
Corticosteroid therapy in borderline tuberculoid leprosy patients co-infected with HIV undergoing reversal reaction: a clinical study. Secchin-De-Andrade, Pedro Jose; Vilas-Boas Hacker, Mariana De Andrea; Sales, Anna Maria; Dalvi-Garci Report Dec 1, 2016 4398
United States : PharmaCyte Biotech Now Awaits U.S. FDA to Advance Pancreatic Cancer Therapy into Pivotal Clinical Trial. Nov 21, 2016 486
Tenax Therapeutics concludes patient enrollment in Phase 3 LEVO-CTS trial of levosimendan in cardiac surgery. Nov 21, 2016 290
Tenax Therapeutics concludes patient enrollment in Phase 3 LEVO-CTS trial of levosimendan in cardiac surgery. Nov 21, 2016 286
Yisheng Biopharma Announces Completion of Phase I Clinical Study of a Novel Hepatitis B Vaccine with PIKA Adjuvant. Nov 21, 2016 630
George Clinical Scientific Leader to Give Talks on Text Messaging Platform That Improves Health Outcomes and Mobilizes Clinical Research. Nov 16, 2016 924
Assembly Biosciences begins Phase 1 clinical trial of ABI-H0731 for treating chronic hepatitis B virus infection. Nov 10, 2016 243
Assembly Biosciences begins Phase 1 clinical trial of ABI-H0731 for treating chronic hepatitis B virus infection. Nov 10, 2016 239
Atox Bio Announces Independent Safety Monitoring Committee Recommendation to Continue Phase 3 Study Of AB103 In Necrotizing Soft Tissue Infections. Nov 3, 2016 573
United States : Dipexium announces top-line data from OneStep Phase 3 trials with Locilex in mild diabetic foot infection did not meet primary clinical endpoint of superiority versus vehicle plus standardized wound care. Oct 26, 2016 501
Entasis initiates Phase I Clinical Trial of ETX2514 for the treatment of severe infections. Oct 26, 2016 200
Entasis initiates Phase I Clinical Trial of ETX2514 for the treatment of severe infections. Oct 26, 2016 196
Dipexium Announces Top-line Data from OneStep Phase 3 Trials with Locilex in Mild Diabetic Foot Infection Did Not Meet Primary Clinical Endpoint of Superiority Versus Vehicle Plus Standardized Wound Care. Oct 25, 2016 1204
United States : Gilead announces SVR12 Rates From Four Phase 3 Studies of a Once-Daily, Fixed-Dose Combination of Sofosbuvir, Velpatasvir and Voxilaprevir in Treatment-Nave and Treatment-Experienced Genotype 1-6 Chronic HCV-Infected Patients. Oct 21, 2016 452
Canada,United States : Merck Announces Pivotal Phase 3 Study of Letermovir, an Investigational Antiviral Medicine for Prevention of Cytomegalovirus (CMV) Infection in High-Risk Bone Marrow Transplant Patients, Met Primary Endpoint. Clinical report Oct 20, 2016 226
MicuRx Initiates Phase 3 Clinical Trial for MRX-I, A New Potent Oral Antibiotic Against Gram-positive Bacteria, Including MRSA. Oct 20, 2016 908
First Ever Human Trial of a Live Attenuated Functioning Therapeutic Herpes Vaccine. Oct 17, 2016 915
Supply Of Clinical Trial Batch In The Area Of Fungal Nail Infection. Oct 5, 2016 162
United States : Achillion announces 100% SVR12 in the 6-Week and 8-Week Cohorts in Janssen's Phase 2 Trial Evaluating the Triple Combination Treatment Regimen Including Odalasvir, AL-335, and Simeprevir for Genotype 1 Treatment-Nave HCV. Sep 24, 2016 581
Synthetic Biologics Announces Completion of Enrollment for Phase 2b Proof-of-Concept Clinical Trial for SYN-004 (ribaxamase) for the Prevention of Clostridium Difficile Infection, Antibiotic-Associated Diarrhea and the Emergence of Antibiotic-Resistant Organisms. Sep 20, 2016 1234
MabVax Therapeutics Reports on Interim Progress on Its Programs Including the Phase I Clinical Trial for Therapeutic Antibody Treatment of Pancreatic Cancer. Sep 19, 2016 1118
Amplyx Pharmaceuticals Initiates Dosing in Phase 1 Clinical Trial of APX001, a Novel Antifungal Product Candidate for Treatment of Life-Threatening Infections. Sep 12, 2016 567
Allakos Initiates Phase 2 Trial of AK001 in Patients with Nasal Polyposis. Sep 8, 2016 714
Novel Antibacterial Drug, exeporfinium chloride, Delivers Encouraging Safety, Tolerability and Efficacy Data in US Clinical Trial. Sep 5, 2016 1462
Novel Antibacterial Drug, exeporfinium chloride, Delivers Encouraging Safety, Tolerability and Efficacy Data in US Clinical Trial. Sep 5, 2016 1468
Caladrius Biosciences product candidate CLBS03 (autologous expanded polyclonal regulatory T cells, or Tregs) was granted Fast Track designation by the FDA for the treatment of type 1 diabetes mellitus (T1D), making it the first known therapeutic candidate for treatment of T1D to receive the designation. Sep 1, 2016 196
Alternative Earthcare Discusses the Miami Zika Outbreak and the Clinical Trial of a Zika Vaccine. Aug 19, 2016 636
NEW THERAPY EXTENDS CANCER PATIENTS' LIVES; Leukaemia drug trial 'offers hope'. Aug 11, 2016 310
BONESUPPORT(TM) Receives FDA Approval to Initiate IDE Clinical Study. Aug 9, 2016 769
BONESUPPORT(TM) Receives FDA Approval to Initiate IDE Clinical Study. Aug 9, 2016 773
United States : ALNYLAM Pharmaceuticals. Initiates phase 1/2 clinical trial with ALN-HBV. Jul 16, 2016 256
Hepatitis B Clinical Trial opens in Australia. Jul 12, 2016 351
Japan : Takeda Initiates World's First Norovirus Vaccine Field Trial. Jun 21, 2016 406
International Clinical Trial Suggests Value Of Venetoclax Combination Therapy In Patients With B-cell Non-Hodgkin Lymphoma. Jun 6, 2016 987
BONESUPPORT(TM) Announces Nature Publication Of Pre-Clinical Study Highlighting CERAMENT(TM)'s Attractive Bone Remodeling Properties and as a Local Drug Delivery Platform for Bone Disease. Clinical report Jun 1, 2016 1052
BONESUPPORT(TM) Announces Nature Publication Of Pre-Clinical Study Highlighting CERAMENT(TM)'s Attractive Bone Remodeling Properties and as a Local Drug Delivery Platform for Bone Disease. Clinical report Jun 1, 2016 1057
Maxwell Biotech Venture Fund's Portfolio Company Hepatera Announces Start of Second Phase 2 Clinical Trial of Myrcludex B in Chronic Hepatitis B/D Infection. May 25, 2016 496
Kineta Receives Wellcome Trust Award to Advance Novel Therapeutic for Lassa Fever Into Clinical Trials. May 5, 2016 941
ContraVir Doses First Subject in Phase 1b Clinical Study of CMX157 for Treating Chronic Hepatitis B Infection. Apr 19, 2016 979
ContraVir Pharmaceuticals doses first volunteer under the Phase 1b clinical study of CMX157 for hepatitis B virus (HBV) infection. Apr 19, 2016 339
ContraVir Pharmaceuticals doses first volunteer under the Phase 1b clinical study of CMX157 for hepatitis B virus (HBV) infection. Apr 19, 2016 335
AbbVie Receives FDA Accelerated Approval of Venclexta(TM) (venetoclax) Tablets, the First BCL-2 Inhibitor in Relapsed/Refractory Chronic Lymphocytic Leukemia Patients with 17p Deletion. Apr 12, 2016 2954
Influenza B Infections Global Clinical Trials Review, H2, 2015. Apr 11, 2016 592
AbbVie Receives FDA Accelerated Approval of Venclexta(TM) (venetoclax) Tablets, the First BCL-2 Inhibitor in Relapsed/Refractory Chronic Lymphocytic Leukemia Patients with 17p Deletion. Apr 11, 2016 2922
Guided Therapy Systems Announces Promising Research from Ultrasound Assisted Drug Delivery Trial at ASLMS 2016. Mar 30, 2016 621
Company applies for Orphan Drug Designation for SCI therapeutic. Mar 28, 2016 340
Regen BioPharma, Inc. Submits IND Application to FDA on tCellVax, a Checkpoint Inhibitor for Cancer Therapy. Mar 23, 2016 653
ContraVir Initiates Phase 1/2a Clinical Study of CMX157 for Treating Chronic Hepatitis B Infection. Clinical report Mar 21, 2016 1057
Company applies to FDA for orphan drug designation for SCI therapeutic. Mar 21, 2016 340
Company applies to FDA for orphan drug designation for SCI therapeutic. Mar 21, 2016 340
Results of Open-Label Trial for CRESEMBA (isavuconazonium sulfate) Treatment of Invasive Mucormycosis Published in The Lancet Infectious Diseases. Mar 9, 2016 1558
Kamedis Announces Positive Clinical Trial Results for First-in-Class Therapeutic Scalp System in Patients with Seborrheic Dermatitis and Moderate to Severe Dandruff. Mar 4, 2016 827
scPharmaceuticals Announces Positive Results from Pivotal Trial of Second Program - Subcutaneous Ceftriaxone for Treatment of Bacterial Infections. Mar 2, 2016 1635
Sangamo BioSciences Presents Phase 2 Immunological Data from SB-728-T ZFP Therapeutic HIV Program at CROI 2016. Feb 24, 2016 1665
Influenza B Infections Global Clinical Trials Review, H1, 2016. Feb 24, 2016 580
Shigella Infections (Shigellosis) Global Clinical Trials Review, H1, 2016. Feb 23, 2016 594
Just Published: "H5N1 Infection (Avian Influenza) Global Clinical Trials Review, H1, 2016". Feb 22, 2016 477
Haemophilus influenzae Infections Global Clinical Trials Review, H1, 2016. Feb 22, 2016 594
Influenza A Infections Global Clinical Trials Review, H1, 2016. Feb 22, 2016 594
H5N1 Infection (Avian Influenza) Global Clinical Trials Review, H1, 2016. Feb 22, 2016 597
Haemophilus influenzae Type B Infections Global Clinical Trials Review, H1, 2016. Feb 22, 2016 587
Just Published: "Clostridium Infections Global Clinical Trials Review, H2, 2015". Feb 18, 2016 467
New cancer therapy shows 'extraordinary' results in early trials. Feb 17, 2016 576
Pelvic Inflammatory Disease (Pelvic Infections) Global Clinical Trials Review, H2, 2015. Feb 17, 2016 578
Clostridium Infections Global Clinical Trials Review, H2, 2015. Feb 17, 2016 576
Epstein-Barr Viral Infections Global Clinical Trials Review, H2, 2015. Feb 17, 2016 605
Neisseria meningitidis Infections Global Clinical Trials Review, H2, 2015. Feb 16, 2016 605
Influenza A Infections Global Clinical Trials Review, H2, 2015. Feb 16, 2016 605
Haemophilus influenzae Type B Infections Global Clinical Trials Review, H2, 2015. Feb 16, 2016 590
Streptococcal Infections Global Clinical Trials Review, H2, 2015. Feb 15, 2016 601
Rotavirus Infections Global Clinical Trials Review, H2, 2015. Feb 15, 2016 614
Staphylococcus aureus Infections Global Clinical Trials Review, H2, 2015. Feb 11, 2016 590
Influenza B Infections Global Clinical Trials Review, H2, 2015. Feb 10, 2016 587
Mycobacterium avium-Intracellulare Infections Global Clinical Trials Review, H2, 2015. Feb 10, 2016 585
Pelvic Inflammatory Disease (Pelvic Infections) Global Clinical Trials Review, H2, 2015. Feb 9, 2016 412
Complicated Skin And Skin Structure Infections (cSSSI) Global Clinical Trials Review, H2, 2015. Feb 8, 2016 416
Chlamydia trachomatis Infections Global Clinical Trials Review, H2, 2015. Feb 3, 2016 588
Skin And Skin Structure Infections (SSSI) Caused By Bacteria Global Clinical Trials Review, H2, 2015. Feb 3, 2016 609
Pseudomonas aeruginosa Infections Global Clinical Trials Review, H2, 2015. Feb 3, 2016 594
Haemophilus influenzae Infections Global Clinical Trials Review, H2, 2015. Feb 3, 2016 592
Complicated Skin And Skin Structure Infections (cSSSI) Global Clinical Trials Review, H2, 2015. Feb 1, 2016 604
Pseudomonas aeruginosa Infections Global Clinical Trials Review, H2, 2015 - New Study Released. Report Feb 1, 2016 416
Randomized controlled trial of hospital-based hygiene and water treatment intervention (CHoBI7) to reduce cholera. George, Christine Marie; Monira, Shirajum; Sack, David A.; Rashid, Mahamud-ur; Saif-Ur-Rahman, K.M.; Feb 1, 2016 6665
Phase II colorectal cancer clinical trial first to receive support, scientific oversight from Van Andel Research Institute-Stand Up To Cancer Epigenetics Dream Team. Jan 28, 2016 1567
A clinical study of vault prolapse in tertiary care hospital. Chandrashekar, K.; Nataraj, K.C. Clinical report Jan 25, 2016 1310
Eisai Submits New Application in Europe for In-House Developed Anticancer Agent Lenvatinib Seeking Approval for Indication Covering Renal Cell Carcinoma. Jan 12, 2016 1223
New Zealand : Wellington student aiming to have new type of cancer therapy on Clinical Trial. Jan 12, 2016 160
National Institutes of Health Initiates Phase 1 Trial of VRC01LS Anti-HIV Therapeutic Antibody Using Xencor's Xtend Fc Technology. Jan 7, 2016 1062
Yisheng Biopharma Announces Positive Results of Phase I Clinical Trial of a Novel Rabies Vaccine with PIKA Adjuvant. Jan 4, 2016 796
Yisheng Biopharma Announces Positive Results of Phase I Clinical Trial of a Novel Rabies Vaccine with PIKA Adjuvant. Jan 4, 2016 837
Skin And Skin Structure Infections (SSSI) Global Clinical Trials Review, H2, 2015. Dec 17, 2015 628
CorMedix Announces Enrollment and Dosing of First Patient in Phase 3 Neutrolin Trial in Hemodialysis. Dec 14, 2015 1207
Sangamo BioSciences Presents Phase 2 Clinical Data From Two SB-728-T HIV Studies. Dec 11, 2015 2003
German Competent Authority Approves ExThera Medical's CE Mark Clinical Trial Protocol. Dec 7, 2015 588
Clostridium Difficile Infections (Clostridium Difficile Associated Disease) Global Clinical Trials Review, H2, 2015. Dec 3, 2015 615
Synthetic Biologics Announces Positive Topline Results from First Phase 2a Clinical Trial of SYN-004, the Company's Candidate for the Prevention of C. difficile Infection. Financial report Dec 1, 2015 1467
MabVax Therapeutics Files IND for Phase I Clinical Trial with HuMab 5B1 as a Therapeutic for Pancreatic Cancer. Dec 1, 2015 1387
Folic acid and creatine as therapeutic approaches to lower blood arsenic: a randomized controlled trial. Peters, Brandilyn A.; Hall, Megan N.; Liu, Xinhua; Parvez, Faruque; Sanchez, Tiffany R.; van Geen, A Report Dec 1, 2015 9281
Antitussive effect of a fixed combination of Justicia adhatoda, Echinacea purpurea and Eleutherococcus senticosus extracts in patients with acute upper respiratory tract infection: a comparative, randomized, double-blind, placebo-controlled study. Barth, Anders; Hovhannisyan, Areg; Jamalyan, Kristina; Narimanyan, Mikael Report Dec 1, 2015 6461
Report: Clostridium Difficile Infections Global Clinical Trials Review, H2, 2015. Report Nov 19, 2015 430
Outcome of ectopic pregnancy: a prospective clinical study in a teaching hospital. Saritha, K.; Sowjanya, R.; Sudha, Sai Nov 19, 2015 1908
Rebiotix Completes Enrollment in Phase 2 Trial of a Microbiota Restoration Therapy (MRT) for the Treatment of Recurrent Clostridium difficile Infection. Nov 18, 2015 694
A double blind, randomized, parallel group, prospective, clinical study for evaluation of efficacy and safety of low dose Doxepin in comparision with Zopiclone in adult and elderly patients with primary insomnia. Rastogi, Pali; Rastogi, Deepti Clinical report Nov 12, 2015 3817
The use of prophylactic single-dose fosfomycin in patients who undergo transrectal ultrasound-guided prostate biopsy: a prospective, randomized, and controlled clinical study. Sen, Volkan; Aydogdu, Ozgu; Bozkurt, Ibrahim Halil; Yonguc, Tarik; Sen, Pinar; Polat, Salih; Degirme Report Nov 1, 2015 3442
Clinical study of ectopic pregnancy. Swami, M.B.; Sharma, Parul; Tyagi, Manvi; Kuswaha, Rinku; Harit, Juhee Clinical report Oct 26, 2015 2235
Clinical study of fistula in Ano. Siddharth, Raj; Kumar, G. Anil; Sreedhar, S. Clinical report Oct 26, 2015 2133
Kiadis Pharma Utilizes BioLife Solutions HypoThermosol to Improve Viability and Shelf Life of Donor Leukocytes in Clinical Trial of ATIR101(TM) T Cell Therapy for Blood Cancers. Oct 19, 2015 922
Clinical study of gallstone disease and treatment options. Rao, Katta Srinivasa; Meghavathu, Govindu Naik; Rao, G. Subba; T., H.R. Prasad Clinical report Oct 1, 2015 2309
Clinical study of carcinoma of oesophagus. Patil, Rajshekhar; Jagdeesh; Reddy, Palla Abhishek Clinical report Sep 28, 2015 2020
Lilly's CYRAMZA (ramucirumab) Significantly Improves Progression-Free Survival in Phase II Bladder Cancer Trial. Sep 28, 2015 4785
New Study: Throat Infection Global Clinical Trials Review, H2, 2015. Report Sep 23, 2015 475
Sangamo Announces Unanimous Recombinant DNA Advisory Committee (RAC) Approval Of ZFP Therapeutic Phase 1 Study Protocol For First In Vivo Genome Editing Application. Sep 10, 2015 926
BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ. Clinical report Aug 31, 2015 996
MicuRX Reports Positive Top-Line Results In Phase 2 Clinical Trial For Novel Antibiotic MRX-I In Complicated Skin And Soft Tissue Infections. Clinical report Aug 31, 2015 647
Now Available: Ancylostomiasis (Hookworm Infections) Global Clinical Trials Review, H2, 2015. Aug 25, 2015 440
Human Papillomavirus Infections Global Clinical Trials Review, H1, 2015 - New Study Released. Report Aug 10, 2015 471
Shigella Infections (Shigellosis) Global Clinical Trials Review, H1, 2015 - New Study Released. Aug 2, 2015 299
MGB Biopharma Commences Phase I Clinical Trial With Oral Formulation of MGB-BP-3 for the Treatment of Multi-Resistant Clostridium Difficile Infections. Jul 21, 2015 766
MGB Biopharma Commences Phase I Clinical Trial With Oral Formulation of MGB-BP-3 for the Treatment of Multi-Resistant Clostridium Difficile Infections. Jul 21, 2015 771
Clinical study on acute pancreatitis. Suhaib, Rehaman A.; Chandrashekhar, S.R.; Prakash J., Reuben Clinical report Jul 20, 2015 3462
Carcinoma penis, clinical study of various modality of treatment. Singh, Vipin Kumar Pal; Yadav, G.D.; Kala, Sanjay; Singh, Anurag; Pantola, Chayanika Clinical report Jul 16, 2015 2733
Herpes Simplex Infections Global Clinical Trials Review, H1, 2015. Jul 8, 2015 576
Pfizer Starts Phase 2b Study Of Its Investigational Multi-antigen Staphylococcus Aureus Vaccine. Jul 7, 2015 461
Pfizer Starts Phase 2b Study Of Its Investigational Multi-antigen Staphylococcus Aureus Vaccine. Jul 7, 2015 430
Oncolytics Biotech[R] Inc. Collaborators Present Final Data from REO 017 Clinical Study in Pancreatic Cancer. Clinical report Jul 6, 2015 1432
Mycoplasma pneumonia infection and asthma: A clinical study. Clinical report Jun 30, 2015 2393
Development, production, packaging and distribution of therapeutic units (biogaran risedronate 75 mg and placebo) for clinical trial. Jun 26, 2015 164
Eisai Announces FDA Approval of FYCOMPA (perampanel) CIII for Adjunctive Therapy in the Treatment of Primary Generalized Tonic-Clonic Seizures in Patients with Epilepsy Age 12 and Older. Jun 22, 2015 2282
FDA clears novel cellular therapeutic approach for ALS trials. Jun 22, 2015 451
Apexigen Doses First Patient in Phase 1 Clinical Trial of Its Immuno-oncology Therapeutic Antibody APX005M. Jun 16, 2015 516
FDA clears novel cellular therapeutic approach for ALS trials. Jun 15, 2015 451
Celyad completes 30-day safety follow-up of first patient in Phase I trial for cell cancer therapy. Jun 11, 2015 185
Symbiomix Therapeutics Doses First Patient in Confirmatory Phase 3 Pivotal Study of Lead Drug Candidate SYM-1219 for Bacterial Vaginosis. Jun 9, 2015 1463
A clinical study of mucocutaneous manifestations of diabetes mellitus. Ramesh, M.; Sreedevi, Chandrika M.; Sharath, Kumar B.C.; Satish, K.S.; Nandini, A.S. Clinical report Jun 8, 2015 4780
Regulus Initiates Phase I Clinical Study of RG-012, a microRNA Therapeutic in Development for the Treatment of Alport Syndrome. Jun 4, 2015 1701
New Collaboration to Dramatically Expand Therapeutic Clinical Trial Access for Cancer Patients Across the United States. May 29, 2015 871
New Collaboration to Dramatically Expand Therapeutic Clinical Trial Access for Cancer Patients Across the United States. May 29, 2015 873
OrthoTrophix Completed Subject Enrollment of the Phase 2 Clinical Trial of a New Cartilage Repair Therapeutic for Knee Osteoarthritis. May 21, 2015 647
Cut throat injuries and it management: a clinical study of 48 patients. Ahmed, Md. Naveed; Rao, M. Sreedhar; Ahmed, S. Muneeruddin; Kumar, M. Mahendra Clinical report May 11, 2015 3829
A clinical study on bedside elective open tracheostomy in ICU of a tertiary hospital in Kerala. Sunil, Kumar K.P.; Divya G.M.; Vijeyta, Dahiya; Muneeruddin, Ahmed S. Clinical report May 7, 2015 4433
Contrafect commences Phase 1 clinical trial of CF-301 for staph bloodstream infections. May 1, 2015 223
Contrafect commences Phase 1 clinical trial of CF-301 for staph bloodstream infections. May 1, 2015 219
Analysis of deep venous thrombosis after Gynecological surgery: A clinical study of 498 cases. Clinical report Apr 30, 2015 2532
Spring Bank Pharmaceuticals Presents Preclinical and Clinical Data on Immunomodulatory Agent SB 9200 at the 2015 Annual Meeting of the European Association for the Study of the Liver. Clinical report Apr 27, 2015 1742
Cardio3 BioSciences infuses 1st patient in Phase I trial of cell cancer therapy. Apr 21, 2015 119
Advanced Inhalation Therapies to Present AIT-RSV Clinical Data at Two Upcoming Medical Meetings. Apr 21, 2015 935
Advanced Inhalation Therapies to Present AIT-RSV Clinical Data at Two Upcoming Medical Meetings. Apr 21, 2015 943
Human Papillomavirus Infections Pipeline H1 2015 Insights and Global Clinical Trials Review Reports. Apr 21, 2015 1193
Human Papillomavirus Infections Pipeline H1 2015 Insights and Global Clinical Trials Review Reports. Apr 21, 2015 1200
Cardio3 BioSciences enrols first patient in Phase I trial for cell cancer therapy. Apr 14, 2015 112
Development, production, packaging and distribution of therapeutic units (risedronate 75mg biogaran and placebo) for clinical trial. Apr 9, 2015 164
IMPACTT: Immunoglobulin IgY pseudomonas A clinical trial for cystic fibrosis treatment. Apr 9, 2015 452
Pivotal Therapeutics and French University Hospital of Strasbourg Announce POMEGA Trial Chief Investigator Dr. Yannick Georg Laureate of EUR 30,000 French Interregional Clinical Research and Innovation Award For Investigating the Therapeutic Value of Its Novel VASCAZEN[R] Formulation in France. Apr 7, 2015 1144
Global Liposarcoma Therapeutic Pipeline and Clinical Trials Review H1 2015. Apr 1, 2015 984
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Global Clinical Trials Review, H2, 2014. Mar 24, 2015 431
Synthetic Biologics Announces Positive Pharmacokinetics Data from Phase 1a and 1b Trials of SYN-004 to Protect the Microbiome and Prevent C. difficile Infection. Mar 19, 2015 1322
New Clinical Study Shows MeMed's ImmunoXpert(TM) Blood Test Can Accurately Distinguish Between Bacterial And Viral Infections. Clinical report Mar 19, 2015 1503
Epic Sciences and The Prostate Cancer Clinical Trials Consortium Collaborate to Advance Therapeutic Development. Mar 9, 2015 752
A clinical study of amniotic fluid index and umbilical artery doppler study at or beyond 34 weeks gestation and its relation to perinatal outcome. Shivalingaiah, Nirmala; Varadarajan, Reethu; Mamatha, M.S. Clinical report Mar 2, 2015 2497
ABIVAX Recruits First Patient in a Pivotal Phase IIb/III Clinical Trial with ABX203, a Novel Immunotherapy Against Chronic Hepatitis B. Feb 26, 2015 1272
Sangamo BioSciences Presents New Clinical Data at CROI 2015 From Trial of ZFP Therapeutic Designed to Provide Functional Control of HIV. Feb 26, 2015 1870
ABIVAX Recruits First Patient in a Pivotal Phase IIb/III Clinical Trial with ABX203, a Novel Immunotherapy Against Chronic Hepatitis B. Feb 26, 2015 1276
Flu Treatment Sponsored By DoD's Medical Countermeasure Systems Takes Major Step Forward In Clinical Trials. Feb 19, 2015 844
Ectopic pregnancy: a clinical study in a tertiary institute. Srilakshmi, Ambarkar; Baleswari, G.; Rajeswari, P. Clinical report Feb 16, 2015 1076
Anticancer Agent Lenvatinib Phase III Trial Results Published In New England Journal of Medicine. Feb 12, 2015 1373
Lenvatinib Phase III Results Published in NEJM Show Significant Improvement in Progression-Free Survival in People With Radioiodine-Refractory Differentiated Thyroid Cancer. Feb 12, 2015 2102
Sangamo BioSciences Announces FDA Acceptance of IND to Initiate Clinical Trial of its Novel ZFP Therapeutic for Beta-Thalassemia. Feb 4, 2015 1203
CTI BioPharma Announces Independent DMC Recommendation to Continue GOG-0212 Phase 3 Study of OPAXIO(TM) as Maintenance Therapy in Ovarian Cancer, an NRG Oncology/GOG Study. Feb 3, 2015 1478
Clinical Trial Shows Benefits of Animal-Assisted Therapy in Adult Cancer Patients Undergoing Complex Cancer Treatment with Chemotherapy and Radiation Therapy. Clinical report Jan 13, 2015 1850
United States : New Clinical Trial Will Evaluate Antibacterial Envelope in Cardiac Implantable Electronic Device Patients at Risk for Major Infections. Jan 8, 2015 415
HIV-1 Infection Global Clinical Trials Review, H2, 2014. Jan 6, 2015 413
SmartClamp circumcision versus conventional dissection technique in terms of parental anxiety and outcomes: a prospective clinical study. Karadag, Mert Ali; Cecen, Kursat; Demir, Aslan; Kivrak, Yuksel; Bagcioglu, Murat; Kocaaslan, Ramazan Clinical report Jan 1, 2015 2680
Synthetic Biologics Announces First Patient Dosed in Phase 1b Clinical Trial of SYN-004 for the Prevention of C. difficile Infection. Dec 30, 2014 1252
Service in the conduct and monitoring of the clinical research acronym etam 2 - 5 (therapeutic melanoma vaccine) implemented. Dec 29, 2014 153
H5N1 Infection (Avian Influenza) Global Clinical Trials Review, H2, 2014. Dec 29, 2014 453
"Gram-Positive Bacterial Infections Global Clinical Trials Review, H2, 2014" Published. Dec 23, 2014 290
Herpes Infections Global Clinical Trials Review, H2, 2014 - New Study Released. Dec 22, 2014 287
Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection. Dec 22, 2014 1355
New Report Available: Ebola Viral Infections Global Clinical Trials Review, H2, 2014. Dec 19, 2014 291
AbbVie Receives U.S. FDA Approval of VIEKIRA PAK(TM) (Ombitasvir/Paritaprevir/Ritonavir Tablets; Dasabuvir Tablets) for the Treatment of Chronic Genotype 1 Hepatitis C. Dec 19, 2014 2442
AbbVie Receives U.S. FDA Approval of VIEKIRA PAK(TM) (Ombitasvir/Paritaprevir/Ritonavir Tablets; Dasabuvir Tablets) for the Treatment of Chronic Genotype 1 Hepatitis C. Dec 19, 2014 2461
Effectiveness of beta-glucan collagen for treatment of partial thickness burns in pediatric age group patients: a randomized controlled trial at tertiary care centre. Changole, Sanjay; Palyekar, Adesh; Nandurkar, Vikrant Clinical report Dec 18, 2014 2681
RELIEF AS LEUKAEMIA DRUG GETS APPROVED; Therapy could cut cancer death toll by 59 per cent, trials show. Dec 9, 2014 309
Hand, Foot and Mouth Disease Therapeutic Pipeline & Clinical Trials H2 2014 Review Research Report. Dec 8, 2014 1251
Synthetic Biologics Announces First Patient Dosed in Phase 1a Clinical Trial of SYN-004 for the Prevention of C. difficile Infection. Dec 2, 2014 1308
Clinical study and surgical management of diabetic foot: a prospective single institutional study. Ananda, B.B.; Ravishankar, K.S. Clinical report Dec 1, 2014 2651
Comparison of the short-term effectiveness of short-wave diathermy treatment in patients with carpal tunnel syndrome: a randomized controlled trial. Boyaci, Ahmet; Tutoglu, Ahmet; Koca, Irfan; Kocaturk, Ozcan; Celen, Esra Dec 1, 2014 3204
Clinical study and surgical management of perforated duodenal ulcer. Pramod, D.; Rajanna, B.; Ramesh M.K.; Manjunath C.S. Clinical report Nov 24, 2014 4232
Synthetic Biologics Safe-to-Proceed Under IND to Initiate Clinical Trials of SYN-004 for the Prevention C. difficile Infection. Nov 24, 2014 1359
Ebola Viral Infections Global Clinical Trials Review, H2, 2014. Nov 19, 2014 397
OrthoTrophix Completed Patient Treatments in Part A of the Phase 2 Clinical Trial of a New Cartilage Repair Therapeutic for Knee Osteoarthritis and Initiated Patient Enrollment for Part B. Nov 17, 2014 638
Phase II NIH/NCI Research for Nanoencapsulated RNAi Cancer Therapeutic. Nov 11, 2014 142
Novira Therapeutics Announces Presentation of Phase 1a Safety and Pharmacokinetic Data for NVR 3-778. Nov 10, 2014 790
EU-funded Consortium Led by Immatics and BioNTech to Advance a Novel Class of Fully Personalized Therapeutic Cancer Vaccines into Clinical Trials for Brain Cancer. Oct 14, 2014 1489
EU-Funded Consortium led by immatics and BioNTech to Advance a Novel Class of Fully Personalized Therapeutic Cancer Vaccines into Clinical Trials for Brain Cancer. Oct 14, 2014 1660
EU-funded Consortium Led by Immatics and BioNTech to Advance a Novel Class of Fully Personalized Therapeutic Cancer Vaccines into Clinical Trials for Brain Cancer. Oct 14, 2014 1484
EU-Funded Consortium led by immatics and BioNTech to Advance a Novel Class of Fully Personalized Therapeutic Cancer Vaccines into Clinical Trials for Brain Cancer. Oct 14, 2014 1664
Clinical study of fever with Thrombocytopenia. Rekha, M.C.; Sumangala, B.; Ishwarya, B. Clinical report Oct 9, 2014 1914
Ruthigen Initiates Phase 1/2 Clinical Trial of RUT58-60. Oct 8, 2014 892
Pinnacle Biologics, Inc., a subsidiary of Concordia Healthcare Corp., announces European site initiation of Phase 3 bile duct cancer trial using photodynamic therapy with PHOTOFRIN[R]. Oct 7, 2014 1680
REPLICor to Present Updated Clinical Trial Data with Combination Treatment Using its HBsAg-release Inhibitors in Patients with Chronic Hepatitis B Infection at the 10th Annual Meeting of the Oligonucleotide Therapeutics Society (OTS). Oct 7, 2014 250
Clinical study and management of choledocholithiasis. Chandu, Suresh Clinical report Oct 2, 2014 2625
Clinical study of acute poisoning. Panduranga M.S.; Rangaswamy Clinical report Sep 18, 2014 3448
A clinical study of mucocutaneous manifestations of HIV. Murugesh, S.B.; Nandini, A.S.; Ravindra, K.; Ramya, N. Clinical report Sep 15, 2014 4729
A clinical study and management of abdominal injuries. Sreenidhi, G.M.; Venugopal, K.; Nandeeshkumar, G.N. Clinical report Sep 11, 2014 4548
New Clinical Study Shows ICU Medical Infusion Systems Are Associated with a Reduction in Both Hazardous Drug Exposure and Central Line-Associated Bloodstream Infections. Clinical report Sep 5, 2014 701
Novira Therapeutics Announces Successful Completion of Phase 1a Clinical Study of NVR-1221 and Commencement of Phase 1b Clinical Studies. Sep 4, 2014 604
Synthetic Biologics to begin SYN-004's clinical trial in 4Q 2014 to prevent C. difficile infections. Sep 3, 2014 265
Synthetic Biologics to begin SYN-004's clinical trial in 4Q 2014 to prevent C. difficile infections. Sep 3, 2014 261
Synthetic Biologics to Initiate Clinical Trials of SYN-004 in 4Q 2014 to Prevent Potentially Deadly C. difficile Infections. Sep 2, 2014 1350
Aethlon Medical Announces Receipt of IRB Approval to Initiate Hemopurifier Clinical Studies. Sep 2, 2014 1152
Surgical site infection in abdominal surgeries: a clinical study. Agrawal, Amit; Singh, R.P. Clinical report Sep 1, 2014 2487
Ruthigen Receives Recommendation from Data Monitoring Committee to Initiate Phase 1/2 Human Clinical Trial of RUT58-60. Aug 26, 2014 1187
Concordia Healthcare Corp. initiates Phase 3 bile duct cancer trial using photodynamic therapy with PHOTOFRIN[R]. Aug 5, 2014 1189
First Clinical Data of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development. Jul 31, 2014 1076
A trial of low dose anti snake venom in the treatment of poisonous snake bites in BRIMS Teaching Hospital, Bidar. Vijay, Kumar B.A.; Gudge, Sachin; Mithare, Shivkumar; Mudbi, Satish; Kulkarni, Shahank Medical condition overview Jul 28, 2014 3861
Clinical study of abdominal hollow visceral perforation-non traumatic. Vinod, Kumar B.; Mathew, A.S. Clinical report Jul 28, 2014 1936
Dipexium Pharmaceuticals Initiates Second of Two Pivotal Phase 3 Clinical Trials of Locilex in Patients with Mild Infections of Diabetic Foot Ulcers. Jul 21, 2014 984
Dipexium Pharmaceuticals Initiates Pivotal Phase 3 Clinical Trial of Locilex in Patients with Mild Infections of Diabetic Foot Ulcers. Jul 17, 2014 1108
Seres Health Completes Enrollment in a Clinical Study for SER-109 in Recurrent Clostridium difficile Infection and Announces Positive Preliminary Data. Jul 16, 2014 772
GlycoVaxyn announces the initiation of a Phase I clinical trial in collaboration with Janssen for a vaccine against Extra-intestinal pathogenic Escherichia coli causing urinary tract infection. Jul 1, 2014 715
GlycoVaxyn announces the initiation of a Phase I clinical trial in collaboration with Janssen for a vaccine against Extra-intestinal pathogenic Escherichia coli causing urinary tract infection. Jul 1, 2014 696
VirtualScopics, Inc. Signs An Alliance Framework Agreement With IXICO plc; Commercial And Operational Alliance To Provide Clinical Trials Industry With Global Capabilities And A Full Range Of Therapeutic Areas And Modality Expertise. Jun 27, 2014 618
Takara Bio Submits IND Application to FDA for HF10 Anti-cancer Therapy. Jun 16, 2014 260
Clinical Study Results Demonstrate Therapeutic Advantages Of The Boston Scientific Vercise(TM) DBS System For Patients With Parkinson's Disease. Clinical report Jun 10, 2014 1342
Clinical Study Results Demonstrate Therapeutic Advantages Of The Boston Scientific Vercise(TM) DBS System For Patients With Parkinson's Disease. Clinical report Jun 10, 2014 1331
Clinical profile and management of liver abscess by USG guided aspiration in combination with antibiotics and surgery: a clinical study. Ojha, Amit; Tiwari, Shaleen Clinical report Jun 2, 2014 4297
Sangamo BioSciences And City of Hope Granted Strategic Partnership Award From California Institute for Regenerative Medicine To Support Clinical Trial Of Stem-Cell Based ZFP Therapeutic For HIV/AIDS. May 30, 2014 1446
Aethlon Medical Announces Definitive Agreement with DaVita Clinical Research and Site Location and Principal Investigator of Hepatitis C Virus (HCV) Clinical Study. Clinical report May 20, 2014 1595
Oncolytics Biotech[R] Inc. Collaborators to Present Positive Brain Cancer Clinical Trial Data at the 50th Annual ASCO Meeting. May 20, 2014 864
Sanofi Pasteur Announces Favorable Phase II Study Results for Investigational Clostridium difficile Vaccine at the American Society for Microbiology Meeting. Report May 19, 2014 1956
Novira Therapeutics Begins Phase 1a Clinical Study of NVR-1221 for the Treatment of Chronic Hepatitis B (HBV) Infection. May 8, 2014 668
Ruthigen Submits Investigational New Drug (IND) Application for Clinical Trial of RUT58-60. May 2, 2014 1033
Takara Bio Completes Enrollment for Phase I Clinical Trial in the US for HF10 Anti-Cancer Therapy. Apr 15, 2014 166
Tetraphase Pharmaceuticals' eravacycline awarded US FDA's Fast Track designation for two formulations and for two therapeutic indications. Apr 3, 2014 265
Tetraphase Pharmaceuticals' eravacycline awarded US FDA's Fast Track designation for two formulations and for two therapeutic indications. Apr 3, 2014 261
Inflammatory response to trauma: a prospective clinical study. Aneja, Arun; Yang, Edward; Xiang, Lusha; Liu, Boshen; Mittwede, Peter; Walker, Clark; Hester, Robert Report Apr 1, 2014 2522
The effects of glyceryl trinitrate patch on the treatment of preterm labor: a single-blind randomized clinical trial. Nankali, Anisodowleh; Jamshidi, Parnian Kord; Rezaei, Mansour Clinical report Apr 1, 2014 4408
American Journal of Obstetrics & Gynecology Publishes New Clinical Study on the Relationship Between Imaging and OVA1 in Assessing Risk of Ovarian Cancer. Mar 20, 2014 2390
Tocagen Doses First Patient Intravenously in Clinical Trial of Selective Cancer Therapy, Toca 511 & Toca FC. Mar 11, 2014 1073
Boehringer Ingelheim Announces Phase 3 SVR12 Results in HCV/HIV Co-Infected Patients Treated with Faldaprevir. Financial report Mar 6, 2014 1263
Sangamo Presents Clinical Data At CROI 2014 Demonstrating Enhancement Of SB-728-T Engraftment - Continued Control Of HIV Viral Load For 31 Weeks Without ART In SB-728-T Treated Subject. Clinical report Mar 6, 2014 2921
Aethlon Medical Announces Agreement with DaVita Clinical Research. Feb 26, 2014 1138
DoD's Joint Project Manager Medical Countermeasure Systems (JPM-MCS) Announces Start of Human Clinical Trial for Ebola Therapeutic. Feb 24, 2014 462
Phase III Select Trial of Lenvatinib Meets Primary Endpoint of Improved Progression Free Survival in the Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer. Feb 3, 2014 1542
Merseyside doctors lead the way with cancer vaccine trial; Professor Daniel Palmer talks about the latest advancements in treatment for pancreatic cancer. Jan 31, 2014 835
Cell Therapeutics Announces GOG Completes Patient Enrollment in GOG-0212 Phase 3 Clinical Trial of Paclitaxel Poliglumex (Opaxio(TM)) as Maintenance Therapy in Ovarian Cancer. Jan 28, 2014 1420
BioLineRx Receives Approval to Commence Pivotal Trial for Novel Skin Lesion Treatment. Jan 21, 2014 1398
Seres Health Announces Interim Clinical Data for SER-109 in Recurrent C. difficile. Jan 13, 2014 959
Another Win in the Fight Against Recurrent Prostate Cancer: Dietary Supplement PHC Performs Well in Phase II Clinical Trials. Jan 7, 2014 784

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters